Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HSBC Holdings | 9.09% | $89.20M | £220.77B | 51.99% | 80 Outperform | |
| AstraZeneca | 8.40% | $82.40M | £210.86B | 19.89% | 80 Outperform | |
| Shell (UK) | 6.65% | $65.29M | £158.23B | 4.31% | 73 Outperform | |
| Unilever | 4.36% | $42.82M | £107.74B | -5.19% | 72 Outperform | |
| Rolls-Royce Holdings | 4.23% | $41.50M | £102.13B | 124.42% | 71 Outperform | |
| British American Tobacco | 3.84% | $37.63M | £94.95B | 36.88% | 71 Outperform | |
| GlaxoSmithKline | 3.09% | $30.30M | £75.70B | 33.56% | 77 Outperform | |
| BP p.l.c. | 3.00% | $29.39M | £71.35B | 9.78% | 71 Outperform | |
| Rio Tinto | 2.87% | $28.17M | £113.21B | 37.76% | 82 Outperform | |
| Barclays | 2.79% | $27.34M | £67.09B | 63.70% | 78 Outperform |